ArticleCancer immunology, immunotherapy : CII2024

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.

Qiaoyun Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.